Discovery Limited · JSE:DSY
Discovery — FY2012 Earnings Presentation
86 slides from Discovery's earnings presentation, 2012
Slide 1: Financial results for the year ended 30 June 2012
Financial results for the year ended 30 June 2012 Adrian Gore, Group Chief Executive Officer, Discovery 1
Slide 2: Discovery is disrupting all the markets it plays in
Discovery is disrupting all the markets it plays in 100% 100% 100% 100% 75% 75% 75% 75% 25% 20% 2
Slide 3: Excellent financial results with new business up 24%
Discovery produced excellent financial results with new business increasing by 24% to R9.3bn, operating profit increasing by 21% to R3.4bn and normalised headline earnings growing by 14% due to increased investment in new businesses. Embedded value grew by 12% to R30.2bn. 3
Slide 4: Discovery's core purpose, ambition and methodology
Discovery’s core purpose, ambition and methodology Core purpose Ambition Methodology An insurance organisation Utilise powerful financial comparable to the best in and behavioural structures Make people the world that is renowned that meet people’s complex for excellence, innovation healthier and ne
Slide 5: Our ambition level defined
Our ambition level defined Use the business model to make a real, positive impact for Modus operandi consumers through profound innovation. Be in the top 3 provider in each category of business, with high levels of profitability, excellent return on capital, and a meaningful Ambition social impact E
Slide 6: Discovery is disrupting all the markets it plays in
Discovery is disrupting all the markets it plays in 100% 100% 100% 100% 75% 75% 75% 75% 25% 20% Manages Largest pure Largest #1 writer of 9% share of Top 4 PMI Top 4 Largest full-scale wellness #1 in Group Market largest risk writer in wellness endowment personal provider in provider in programme in
Slide 7: Discovery's product and expansion models
Discovery’s product and expansion models Capital-light, organic growth, Unique, disruptive, repeatable phased incubation High dividend cover; 5%-7% IP-led, capital-light Financial partnerships Health Life Services Wellness and consumer engagement Superior products; Innovation margin; #1 in new busin
Slide 8: Earnings growth
Earnings growth 21% Earnings growth R millions 33% 27% 31% 14% 20% 20% 102% 11% 48% 48% 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Earnings growth vs CPI 40% 30% 20% 10% 0% 2006 2007 2008 2009 2010 2011 2012 CPI Earnings above CPI 8
Slide 9: Return on Capital
10% 15% 20% 25% 30% 0% 5% Jun-04 Oct-04 Feb-05 Jun-05 Oct-05 Return on Capital Feb-06 Jun-06 Oct-06 Return on capital vs risk-free Feb-07 Jun-07 Oct-07 Feb-08 Jun-08 Risk-free Oct-08 Feb-09 Jun-09 ROC Oct-09 Feb-10 Jun-10 Oct-10 Feb-11 Jun-11 Oct-11 Feb-12 Jun-12 Risk free + 11 - 17% 9
Slide 10: Capital allocation strategy
Capital allocation strategy Capital expenditure (Rm 2011) Capital expenditure (Rm 2012) 2,286 1,730 1,546 225 68 23 Life* Insure UK US China Life* Insure UK US China Capital-light, IP-led approach with allocation to certainty Note: Using internally-generated cash 10
Slide 11: Capital allocation strategy positions Discovery for future growth
Capital allocation strategy positions Discovery for future growth Integrated business attained scale in the UK, representing 9% of operating profit Rapid capture of personal lines new business market share (9%) on a run-rate basis one year after launch Wholesale distribution capability expanding thr
Slide 12: Attainment of scale in the UK
Attainment of scale in the UK Combined premium (Rm) Combined operating profit (Rm) 5,000 500 4,500 400 4,000 300 3,500 3,000 200 2,500 100 2,000 - 1,500 -100 1,000 500 -200 2010 2011 2012 - 2010 2011 2012 Core profit TSA 12
Slide 13: Overview of performance
Overview of performance Normalised profit from operations +21%; Strong new business API +24%, including solid growth in new businesses; Embedded Value +12%; Over 5.8 million unique lives covered internationally Operating profit +10% including R100 million reduction in DHMS admin fee; Overall new bus
Slide 14: Overview of performance
Overview of performance R91m operating profit +28%; Excellent performance on key drivers of loss ratio and lapse rate; Focus on quality new business; High Vitality Plus take-up Operating profit of R209m; Strong new business with excellent receptivity to new product launch; Higher-profitability new b
Slide 15: Performance for the 12 months ended 30 June 2012: New business API
Performance for the 12 months ended 30 June 2012 New business API New business 12 months to 12 months to % R millions 30 June 2012 30 June 2011 change Annualised new business 9 328 7 543 24% Established 4 282 3 904 10% 1 749 1 620 8% 171 147 16% 961 853 13% 460 290 59% 592 609 (3%) New 239 n/a 515 3
Slide 16: New business growth
New business growth New business API R millions 9,328 7,618 7,543 5,786 4,819 4,066 3,532 3,630 2,770 2,719 2,133 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 16
Slide 17: Profit from operations
Performance for the 12 months ended 30 June 2012 Profit from operations Profit from operations 12 months to 12 months to % R millions 30 June 2012 30 June 2011 change Established 1 499 1 357 10% 1 819 1 591 14% 5 18 (72%) 151 101 50% 300 (15) n/a PruHealth 91 71 28% PruProtect 209 (86) n/a Total for
Slide 18: Profit from operations
Performance for the 12 months ended 30 June 2012 Profit from operations Profit from operations 12 months to 12 months to % R millions 30 June 2012 30 June 2011 change Established 1 499 1 357 10% 1 819 1 591 14% 5 18 (72%) 151 101 50% 300 (15) n/a Total for established businesses 3 774 3 052 24% New
Slide 19: Results headlines
Performance for the 12 months ended 30 June 2012: Results headlines Actual Actual % R million 2012 2011 change Normalised profit from operations 3,443 2,846 21% Investment income, finance charges & foreign exchange 160 43 Normalised profit before tax 3,603 2,889 25% Tax on normalised operations (1,2
Slide 20: Embedded value progression
Embedded value progression Group Embedded Value R million 35,000 30,000 12% 19% 25,000 13% 20,000 12% 26% 15,000 34% 15% 10,000 5,000 - Jun-05 Jun-06 Jun-07 Jun-08 Jun-09 Jun-10 Jun-11 Jun-12 EV of R30.2bn, diluted EV per share of R53.78 20
Slide 21: Embedded value detail
Embedded value detail SA experience variances EV methodology and assumption changes R millions R millions 1,076 351 193 6 15 25 -157 -25 -69 -113 -201 -566 -721 -1,032 -905 Total Excl Mortality and Policy Expenses Lapses and Other Lapses Mortality and Admin Premium and Reinsurance Modelling Economic
Slide 22: Discovery Health
iy) Discovery
Slide 23: Key financial metrics
Key financial metrics Actual Actual % change 2012 2011 New business API (Rm) 4,282 3,904 10% Discovery Health lapses 3.9% 3.9% Operating profit (Rm) 1,499 1,357 10% Principal members 1,236,353 1,166,722 6% DHMS 1,113,759 1,054,315 6% In-House 122,594 112,407 9% 23
Slide 24: Discovery's role is to improve cost, access and quality of healthcare
Discovery’s role is to improve cost, access and quality of the healthcare system for its members Access to care Quality Cost of care 24
Slide 25: Cost: premium and inflation competitiveness
Cost: Premium and inflation competitiveness 5 year annualised increases relative to CPI Relative comparison of average % contributions for a family of 4 100 100 100 100 91 6.1 85 Average for largest open schemes = 4.8% 77 10 largest open schemes (excl. Discovery) 10 largest open schemes (excl. Disco
Slide 26: Access: Extensive direct payment arrangements and coverage
Access: Extensive direct payment arrangements and coverage % of consultations with doctors on direct payment arrangements Specialists GPs 95 93 95 92 93 98 95 93 88 90 86 90 88 91 87 83 84 77 80 Gauteng Limpopo Mpumalanga KZN Northwest FS Northern Western Cape Eastern Cape Total Cape Coverage ratio
Slide 27: Quality: HealthID revolutionising the point of care
Quality: HealthID revolutionising the point of care Unique logins – per month 500 400 300 200 100 0 May may Jun june Jul july Aug august Client consents Electronic health records | e-scripting | 40,000 chronic illness benefits | benefit details 35,000 and cover | electronic referrals | 30,000 emerge
Slide 28: Growth in DHMS membership base with low lapses
Growth in DHMS membership base with low lapses Growth in DHMS membership base Low lapse rates Membership progression Annual DHMS lapse rates Number of lives (%) 2,500,000 6.0% 4.9% 5.0% 2,000,000 4.2% 4.3% 3.9% 4.0% 3.8% 1,500,000 3.0% 1,000,000 2.0% 500,000 1.0% - 1993 1994 1995 1996 1997 1998 1999
Slide 29: Stability in plan choices
Stability in plan choices 2010 2011 2012 Downgrade Upgrade Downgrade Upgrade Downgrade Upgrade 2.2% 4.1% 2.1% 3.8% 2.2% 3.5% No change No change No change 93.7% 94.1% 94.4% 29
Slide 30: Membership highest in the industry and continues to grow
Membership highest in the industry and continues to grow Scheme growing relative to Largest open medical scheme competitors Beneficiaries by scheme, 2011 Net growth in lives Number 31 Dec 2006 – 30 Sept 2011 2,500,000 600,000 466,891 400,000 2,000,000 200,000 0 1,500,000 -200,000 1,000,000 -400,000
Slide 31: DHMS has strengthened its financial position
DHMS has strengthened its financial position Highest possible credit rating Highest reserves in the industry (for the past 12 yrs) Reserve progression Rands Medical Fund GCR Rating Discovery AA+ 8,000,000 7,000,000 Medihelp AA- 6,000,000 Fedhealth AA- 5,000,000 Medshield AA- 4,000,000 Liberty AA- 3,
Slide 32: Admin fee evolution
Admin fee evolution Admin fee glide path DHMS historical trend 16% 16% 14% 12% 14% 10% 8% 12% 6% 4% 10% 2% 0% 8% 2011 2005 2006 2007 2008 2009 2010 DHMS 2012 SA 25th SA 75th US DHMS target percentile percentile commercial 32
Slide 33: South African healthcare system
South African healthcare system “Opinion is split between people who argue that healthcare costs are driven up by older, sicker people using their medical aids regularly, and others who think it is a reflection of market power” 33
Slide 34: Private healthcare system is world class
Private healthcare system is world class Egalitarian Open enrolment, flat community rating No networks or restrictions with virtually no Open access waiting times Limited co-pays required due to extensive Minimal out-of-pocket direct payment arrangements (over 90% of specialists covered, 85% of GPs)
Slide 35: Understanding medical inflation
Understanding medical inflation Contributors to medical Impact on medical inflation of DHMS Conclusions inflation interventions 6-11 A Medical inflation largely driven by demand side and supply side factors – tariffs 2.0 closely correlated with CPI 1-3 E -3.6 0.7 0.3 0.6 2-7 B Egalitarian system is
Slide 36: Discovery Life
iy) Discovery Discovery Life
Slide 37: Key financial metrics
Key financial metrics 12 months 12 months % to 30 June 2012 to 30 June 2011 change New business R1,749m R1,620m 8% Individual business R1,611m R1,460m 10% Operating profit R1,780m R1,558m 14% Value of in-force R12,358m R10,592m 17% 37
Slide 38: Traditional underwriting model
Traditional underwriting model: Assumes uniformity across the population Average market price Risk Features of model: 1 Average pricing basis 2 Anti-selective lapsation 3 No incentive to improve health Age 38
Slide 39: Mechanics of Integrated Discovery Life model
Mechanics of Integrated Discovery Life model Comprehensive and Priority Vitality Status Plans (Principal) Health Claims (including MSA) Blue Bronze Silver Gold 0 to R1 650 0.00% 0.00% -0.50% -2.00% R1 651 to R2 550 1.35% 1.00% 0.00% -1.00% R2 551 to R3 650 2.10% 1.85% 1.00% -0.50% R3 651 to R7 400 2
Slide 40: Dynamic underwriting model
Dynamic underwriting model: Premium based on ongoing health engagement Average market price Risk Unhealthy Average Discovery price Healthy Age 40
Slide 41: Impact of the dynamic underwriting model
Impact of the dynamic underwriting model EV per policy EV per Vitality Status should be Value consistent Blue Bronze Silver Gold Diamond Better retention and positive Risk Unhealthy Lapse Lapses Stay selective lapsation Healthy Age Annual mortality experience variance Better emerging mortality Morta
Slide 42: Impact of the underwriting approach: lapse and mortality experience
Impact of the underwriting approach: Lapse and mortality experience 6-month lapse experience relative to assumption Annual mortality experience variance (Rm) 250 200 150 100 Dec 07 Dec 05 Dec 06 Dec 08 Dec 09 Dec 10 Dec 11 Jun 05 Jun 06 Jun 07 Jun 08 Jun 09 Jun 10 Jun 11 Jun 12 50 6 monthly lapse ex
Slide 43: Actual versus expected health claims and Vitality Status
Actual versus expected health claims and Vitality Status across the Discovery Life Integrator population 3 Above expectation 2.5 Number of members: Actual to Expected 2 1.5 Below expectation 1 38501+ 27421 - 38500 16491 - 27420 0.5 Health claims 11091 - 16490 5471 - 11090 0 3301 - 5470 Blue Bronze 0
Slide 44: Value of in-force per policy by Vitality Status
Value of in-force per policy by Vitality Status Expected VIF per status Blue Bronze Silver Gold & Diamond 44
Slide 45: Refinement of Vitality structures
Refinement of Vitality structures: Move towards greater outcomes basis Vitality Check Level 5: 15 000 Fitness Level 4: 13 000 Assessment Level 3: 10 000 Level 2: 7 500 Participation: 3 000 45
Slide 46: EV impact of lapses and mortality experience
EV impact of lapses and mortality experience 18,000 16,000 14,000 12,000 10,000 8,000 6,000 4,000 Claims 10% better 2,000 No change - Lapses +10% Claims 10% worse No change Lapses -10% Claims 10% worse No change Claims 10% better 46
Slide 47: Discovery Invest
iy) Discovery
Slide 48: Key financial metrics
Key financial metrics 12 months 12 months % to 30 June 2012 to 30 June 2011 change New business APE R961m R853m 13% Single (not indexed) R4,324m R4,015m 9% Recurring R424m R351m 21% Guaranteed Bonds (not indexed) R1,031m R1,002m -2% Funds under management R25,2bn R17.2bn 47% Operating profit R151m R
Slide 49: Assets under management have grown significantly
Assets under management have grown significantly Assets under management Rbn 0-R10bn in 34 months R10-R20bn in 16 months >R25bn currently 2007 2008 2009 2010 2011 2012 49
Slide 50: Discovery Insure
iy) Discovery Discovery Insure
Slide 51: 'Perfect storm' of factors informed entry into short-term insurance
‘Perfect storm’ of factors informed Discovery’s entry into the short-term insurance market 1 2 3 4 Availability of existing technology to understand Inherent Discovery Core purpose Behavioural paradox and reward good capabilities behaviour Making people Survey data” “How Telematics healthier and wou
Slide 52: Discovery Insure product construct
Discovery Insure product construct State-of-the-art vehicle and ImpactAlert™: Stolen vehicle Vehicle Protector™: Family Protector™: passenger safety Pro-active recovery at no Tools to improve Additional family emergency additional cost vehicle safety safety features response Comprehensive motor insu
Slide 53: New business sales are excellent
New business sales are excellent Average daily new business API sales R millions Personal lines insurance market share of ~9% at current run rate 1.7 1.3 1.2 1.1 0.94 0.91 0.86 0.7 Jan Feb Mar Apr May Jun Jul Aug 53
Slide 54: Creating a nation of better drivers
Slide 55: Vitalitydrive is enabling a substantial shift in consumer choice
Vitalitydrive is enabling a substantial shift in day-to-day consumer choice Clients are changing their driving behaviour Clients responding to fuel incentive Indexed Driver Performance Scores 311 100 (Month 1 = 100) fuel transactions 7.7m ℓitres 77 118 of fuel purchased at BP 116 114 112 110 108 106
Slide 56: Quality of new business is excellent
Quality of new business is excellent Correlations are proving to be correct Positive selection Claims frequency by DQ points band Relative lapse rates by Vitalitydrive status (Band 1 = 100) (Base = 100%) 100 100% Relative lapse rate (Base = 100%) 74 80% 60% 48 40% 23 20% 0% Band 1 Band 2 Band 3 Band
Slide 57: Attractive client profile
Attractive client profile Loss ratios declining Number of Discovery products 2012H1 =1 40% 1.00 0.95 35% Proportion of Discovery Insure clients 30% 25% 20% 15% 10% 5% 0% 0 1 2 3 4 H1 H2 57
Slide 58: SmartQuote from Discovery Insure
SmartQuote from Discovery Insure 58
Slide 59: PruHealth and PruProtect
iy) Discovery J{PRUHEALTH 4 2/PRUPROTECT
Slide 60: Attainment of scale in the UK
Attainment of scale in the UK Combined premium (Rm) Combined operating profit (Rm) 5,000 500 4,500 400 4,000 300 3,500 3,000 200 2,500 100 2,000 - 1,500 -100 1,000 500 -200 2010 2011 2012 - 2010 2011 2012 Core profit TSA 60
Slide 61: PruHealth
iy) Discovery 3 /PRUHEALTH
Slide 62: Key financial metrics
Key financial metrics 12 months 12 months % to 30 June 2012 to 30 June 2011 change New business R592m R609m (3%) Operating profit (100%) R91m R71m 28% Cost of Transitional Services (R100m) (R103m) (3%) Agreement Note: Period to June 2011 includes Standard Life Healthcare from 1 August 2010 62
Slide 63: Strategic thrusts over the period
Strategic thrusts over the period Bed-down the Standard Life Healthcare 1 acquisition Manage the ongoing quality of the in-force 2 portfolio 3 Enhance the member experience Generate business of exceptional quality 4 and margin 63
Slide 64: Investment in PruHealth and PruProtect's capability in the UK
Investment in PruHealth and PruProtect’s capability in the UK Financial impact of TSA extension Development of Target Operating Model (Rm) 200 175 150 125 100 75 Development of significantly enhanced and 50 flexible claims, admin, online systems 25 New data warehouse - New infrastructure Profit TSA
Slide 65: Absolute focus on quality: loss ratio and retention
Absolute focus on quality: Loss ratio and retention 12-month rolling loss ratio Lapse rate by loss ratio band (FY2010= 100%) (ex-SLH SME; Low loss ratio = 100%) 100% 400% 90% 350% 300% 80% 250% 70% 200% 150% 60% 100% 50% 50% 40% 0% FY2010 FY2011 FY2012 Low High Loss ratio band 20% reduction in lapse
Slide 66: Enhance the member experience
Enhance the member experience: Full Refund and London Hospital list Full Refund Hospital Efficiency: Merging of London and Countrywide lists Rolling 12 month Professional PLPM 20% Reduction to ave Ave London + 15% London rate 10% 5% 0% -5% Ave London - -10% -15% -20% -25% -30% Jul Aug Sep Oct Nov De
Slide 67: Absolute focus on quality: new business by channel
Absolute focus on quality: New business by channel New business (Rm) Market (2011) Market (2012) 700 600 6% 23% 500 31% 42% 400 53% 300 46% 200 100 Individual SME Individual SME 0 2010 2011 2012 Corporate Corporate 67
Slide 68: Improved quality of the in-force membership base
Membership progression: Improved quality of the in-force membership base Membership progression (lives) 750 700 650 600 550 500 450 400 Actual PruHealth membership Expected membership given shock lapse assumption on acquisition Reduction in Corporate lives from 20% to 15% of the portfolio 68
Slide 69: PruProtect
iy) Discovery pat af PRUPROTECT
Slide 70: Key financial metrics
Key financial metrics 12 months 12 months % to 30 June 2012 to 30 June 2011 change New business API R460m R290m 59% Policies in force 109,929 67,886 62% Value of new business (100%) R415m R151m 175% Operating profit / (loss) (R, 100%) R209m (R86m) n/a 70
Slide 71: Repeatability of the model: Payback
Repeatability of the model: Discovery Life and PruProtect product initiatives Integrated Cover Integrated Cover Payback Retirement Optimiser LIFE FUND Life Fund 2000 2002 2004 2005 2006 2008 2009 2010 2011 Family Income Cover Education Protector Whole of Life Cover Relevant Life Cover Business Cover
Slide 72: External validation of the PruProtect model: 2012 Awards
External validation of the PruProtect model: 2012 Awards Innovation Award PruProtect may have won this award last year, however, that didn’t stop further innovation. Since then it has revitalised its whole of life offering, launched a range of new products and options, including Premium Saver, impro
Slide 73: New business development comparison: PruProtect vs Discovery Life
New business development comparison: PruProtect vs. Discovery Life; New business policies (number) New business (number of policies) 3-month rolling average 6,000 Number of policies (per month) 5,000 4,000 3,000 2,000 1,000 - 1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 5
Slide 74: Quality: new business generation by channel
Quality: New business generation; channel High net worth cases*: Production by channel (2011) Production by channel (2012) % of new business 18% 16% 14% 9% 14% 14% 24% 12% 6% 23% 10% 8% 6% 44% 67% 4% 2% Corporate Corporate Direct to Market Direct to Market 0% Franchise Franchise Telephone Account Ma
Slide 75: Quality: claims and lapses
Quality: Claims and lapses Claims: actual to expected 12-month rolling lapse rate (June 2011 = 100%) Cumulative claims 110% 100% 90% 80% 70% 60% 50% 40% Apr-09 Apr-10 Apr-11 Apr-12 Jul-09 Jul-10 Jul-11 Oct-11 Jan-09 Oct-09 Jan-10 Oct-10 Jan-11 Jan-12 Actual Expected 75
Slide 76: Manifestation of the model: scale
Scale - 100,000 120,000 20,000 40,000 60,000 80,000 Oct-07 Jan-08 Policies in-force Apr-08 Jul-08 Oct-08 Manifestation of the model: Jan-09 Apr-09 Jul-09 Oct-09 Jan-10 Apr-10 Jul-10 Oct-10 Jan-11 Apr-11 Jul-11 Oct-11 Jan-12 Apr-12 76
Slide 77: Manifestation of the model: financial performance
Manifestation of the model: Financial performance Operating profit (Rm) Annualised profit margin 250 16% 200 14% 150 12% 100 10% 50 8% - 6% -50 4% -100 2% -150 0% 2010 2011 2012 2011 2012 77
Slide 78: New business market share (IFA channel)
Manifestation of the model: New business market share (IFA channel): Q2 2012 > 9% Q1 2010 Q1 2011 Q1 2012 A 16.3% A 16.6% A 18.8% B 14.1% B 15.5% B 18.2% C 12.0% C 13.3% C 14.4% D 9.6% D 12.5% D 9.1% E 7.3% E 8.8% PruProtect 8.7% F 6.8% F 6.3% E 8.2% G 6.2% PruProtect 5.0% F 8.1% H G G 5.1% 4.8% 5.1
Slide 79: Strategic opportunities
Strategic opportunities Removal of upfront commission on investment Retail Distribution Review products is expected to increase broker- induced demand for protection products EU Gender Directive prohibits premium Gender neutrality differentiation on the basis of gender from 2013 79
Slide 80: Ping An Health
: @Discovery Cpe) PING AN
Slide 81: Prospects and strategies
Prospects and strategies Group high-end Vitality Individual market Roll-out a Penetrate the Individual Become the number 1 comprehensive, local mid-market by leveraging provider in the Group Vitality program to Ping An Life’s extensive high-end market support the actuarial 500,000 person agency dyna
Slide 82: PAH is currently the number 1 writer of Group high-end insurance in China
PAH is currently the number 1 writer of Group high-end insurance in China 2011 2012 YTD Group high end market share % 26 25 20 18 15 15 15 14 12 10 10 8 8 4 PAH China Re Taiping CMB AXA Life China China PAH China Re Taiping CMB AXA Life China Life China Pension CIGNA Life Generali Pension CIGNA Gene
Slide 83: Vitality is now introduced in China
Vitality is now introduced in China Online assessments 20x Clubcard points for fruit Access discounted rates and vegetables 1 Vitality points per RMB 4 of spend Or Up to 1 125 points Download an app Check-ups and fitness assessments Or Purchase fitness monitor Vitality Up 4 275 points for check-ups;
Slide 84: Continued strong growth in sales
Continued strong growth in sales Ping An Health cumulative sales RMB 600 500 400 300 200 100 0 Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun 2011 2012 84
Slide 85: Performance over the period and strategic intent
Performance over the period and strategic intent An insurance organisation comparable to the best in the world that is Ambition renowned for excellence, innovation and financial strength. In addition, the organisation must be a powerful force for social good 2.8m lives Use the business model to make
Slide 86: Financial results for the year ended 30 June 2012
Financial results for the year ended 30 June 2012 Adrian Gore, Group Chief Executive Officer, Discovery 86